Results 121 to 130 of about 119,638 (165)
Some of the next articles are maybe not open access.
Treatment of ventricular arrhythmias
Current Problems in Cardiology, 1988Within the past 20 years, our knowledge concerning the epidemiology, natural history, and treatment of VT has expanded greatly. A variety of effective pharmacologic, surgical and electrical therapies for VT are now available to the clinician. Patients who present with ventricular tachyarrhythmias should undergo a comprehensive medical evaluation ...
B A, McGovern, H, Garan, J N, Ruskin
openaire +2 more sources
Stroke and ventricular arrhythmias
International Journal of Cardiology, 2013Electrocardiographic abnormalities and cardiac arrhythmias are commonly noted after acute stroke. Risk of malignant ventricular arrhythmias is increased after a stroke and is associated with sudden cardiac death. Autonomic imbalance modulated by direct injury to neurogenic structures and enhanced by catecholamine storm can lead to myocardial damage and
Sahil, Koppikar +3 more
openaire +2 more sources
Pindolol for ventricular arrhythmia
American Heart Journal, 1982The role of pindolol in treating ventricular arrhythmia was studied in 43 patients with this disorder. Of these patients, 23 had coronary heart disease, 5 had valvular disease, and 15 had no demonstrable heart disease. patients underwent acute drug testing with 20 mg pindolol (phase 1) followed by maintenance therapy (phase 2) for 3 days (20 to 80 mg ...
P J, Podrid, B, Lown
openaire +2 more sources
Acecainide for Ventricular Arrhythmias
JAMA: The Journal of the American Medical Association, 1982To the Editor.— I would like to comment on the MEDICAL NEWS article entitled "Alter Drug Structure-Avert Induced Lupus" (1981;246:1634) that dealt with the efficacy of acecainide hydrochloride, chemically known as N -acetylprocainamide, in treating ventricular arrhythmias. It was of great interest to learn about Marcus A.
openaire +2 more sources
Ablation of ventricular arrhythmias
Trends in Cardiovascular Medicine, 2014Ventricular arrhythmias (VAs) commonly occur in patients with structural heart disease and may present as ventricular premature depolarizations (VPDs), monomorphic ventricular tachycardia (VT), or polymorphic VT/ventricular fibrillation. Idiopathic VAs can also occur in patients with normal hearts.
Mouhannad M, Sadek +1 more
openaire +2 more sources
Causes of Ventricular Arrhythmias
JAMA: The Journal of the American Medical Association, 1972To the Editor.— In a recent article inThe Journal214:1323, 1970), Barrett and Hey implicated diazepam given intravenously as the cause of ventricular arrhythmias. Since, in the second reported case, ventricular tachyarrhythmia occurred following administration of this drug before electric shock was applied, the application of post hoc, ergo propter ...
openaire +2 more sources
Genetic Basis of Ventricular Arrhythmias
Cardiology Clinics, 2008Sudden cardiac death caused by malignant ventricular arrhythmias is the most important cause of death in the industrialized world. Most of these lethal arrhythmias occur in the setting of ischemic heart disease. A significant number of sudden deaths, especially in young individuals, are caused by inherited ventricular arrhythmic disorders, however ...
Boussy, Tim +7 more
openaire +7 more sources
Ventricular Arrhythmias And Diazepam
JAMA: The Journal of the American Medical Association, 1971To the Editor.— Barrett and Hey's description of ventricular arrhythmias associated with the intravenous use of diazepam ( 214 :1323, 1970) illustrates some of the difficulties in drawing conclusions from uncontrolled isolated case reports. Their first patient had a short burst of ventricular tachycardia after direct current shock, a not infrequent ...
openaire +2 more sources
Mapping of Ventricular Arrhythmias
Cardiology Clinics, 1986Mapping of ventricular arrhythmias is essential for their reliable surgical and ablative management. Activation mapping is the most widely used technique but demands induction of the arrhythmia. Mapping strategies that can identify an arrhythmogenic substrate in sinus rhythm are clinically attractive but require further investigation before their ...
openaire +2 more sources
Postgraduate Medicine, 1991
Patients with asymptomatic ventricular premature complexes who do not have evidence of heart disease should not be treated with either class I or class III (Vaughan Williams) antiarrhythmic drugs. Patients who are symptomatic may be given beta blockers.
openaire +2 more sources
Patients with asymptomatic ventricular premature complexes who do not have evidence of heart disease should not be treated with either class I or class III (Vaughan Williams) antiarrhythmic drugs. Patients who are symptomatic may be given beta blockers.
openaire +2 more sources